CARGO Therapeutics, Inc. (CRGX)
NASDAQ: CRGX · Real-Time Price · USD
4.480
+0.020 (0.45%)
Aug 7, 2025, 4:00 PM - Market closed
Company Description
CARGO Therapeutics, Inc., a clinical-stage biotechnology company, focused on designing, engineering, and developing potentially curative cell therapies for cancer patients in the United States.
The company develops CRG-023, a tri-specific CAR T product candidate which is in phase 1 that targets tumor cells with three B-cell malignancies; and allogeneic platform, a universal vector solution designed to effectively limit immune-based rejection to enable durable response of CAR T-cell therapy.
The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022.
CARGO Therapeutics, Inc. was incorporated in 2019 and is based in San Carlos, California.
CARGO Therapeutics, Inc.
| Country | United States |
| Founded | 2021 |
| IPO Date | Nov 10, 2023 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 167 |
| CEO | Anup Radhakrishnan |
Contact Details
Address: 835 Industrial Road, Suite 400 San Carlos, California 94070 United States | |
| Phone | 650 379 6143 |
| Website | cargo-tx.com |
Stock Details
| Ticker Symbol | CRGX |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $15.00 |
| CIK Code | 0001966494 |
| CUSIP Number | 14179K101 |
| ISIN Number | US14179K1016 |
| Employer ID | 84-4080422 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Anup Radhakrishnan | Interim Chief Executive Officer, Chief Financial Officer, Secretary, Chief Operating Officer and Director |
| Dr. Crystal L. Mackall M.D. | Co-Founder and Scientific Advisory Board Chair |
| Dr. Robbie Majzner M.D. | Co-Founder and Scientific Advisory Board Member |
| Nancy Goodman J.D. | Founder |
| Dr. Louai Labanieh Ph.D. | Founder |
| Halley E. Gilbert Esq., J.D. | Chief Legal Officer |
| Kari E. Leetch | Chief People Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 7, 2025 | SCHEDULE 13G/A | Filing |
| Aug 7, 2025 | SC TO-T/A | Filing |
| Aug 6, 2025 | 10-Q | Quarterly Report |
| Aug 6, 2025 | SCHEDULE 13G/A | Filing |
| Jul 23, 2025 | SC 14D9 | Filing |
| Jul 21, 2025 | SC TO-T | Filing |
| Jul 9, 2025 | SCHEDULE 13D/A | Filing |
| Jul 8, 2025 | 8-K | Current Report |
| Jul 2, 2025 | 8-K | Current Report |
| Jun 20, 2025 | 8-K | Current Report |